PRE-COMMERCIAL PROCUREMENT
REMOTE REHABILITATION SERVICE FOR ISOLATED AREAS
ROSIA (which stands for Remote RehabilitatiOn Service for Isolated Areas), will deliver a comprehensive service to patients in need of rehabilitation, enabled by cutting-edge technology, new care pathways and community support.
PRE-COMMERCIAL PROCUREMENT
REMOTE REHABILITATION SERVICE FOR ISOLATED AREAS
ROSIA (which stands for Remote RehabilitatiOn Service for Isolated Areas), will deliver a comprehensive service to patients in need of rehabilitation, enabled by cutting-edge technology, new care pathways and community support.
THE PROJECT
ROSIA is ready to purchase the design of a technology-enabled all-in-one service, flexible enough to adapt to a large variety of European health-care systems, and which will allow the full development of ROSIA’s model – complementing existing public resources with a public-private partnership.
CONSORTIUM
ROSIA’s PCP project has partners in Spain, Portugal and Ireland; a well-balanced consortium of partner organizations that gather a dream multidisciplinary team.
PCP
PCP – Pre-Commercial Procurement is a tool to stimulate innovation as it enables the public sector to steer the development of market solutions directly towards its needs.
NEWS
TWEETS
ROSIA AT A GLANCE
Our means
ROSIA is ready to deploy a complete solution set for scale-up: it includes an open platform to integrate third-party solutions, a tailored integrated care path, a catalogue of personalized services for patients, a motivational programme realised through community interventions – and all of it aligned in a value-based service model.
Our goals
We hope to accomplish a triple victory: Patients, Healthcare and Entrepreneurship. Patients in rural areas will be able to work through their rehabilitation programs from home and to extend them as much as they need. The healthcare system will be able to increase its capacity with current resources. And the European business community will have a chance to penetrate an up until now locked-up healthcare system
Who will benefit?
ROSIA aims to design future rehabilitation services for remote rural areas, based on disruptive technologies, and supported by a continuous care model.
Seven pathologies have been selected to test the system: chronic spinal cord injury, acquired brain injury, COPD, arthroplasty, cardio-vascular disease, hip fracture, and COVID-19.
Go-To-Market
ROSIA is eager to unlock the entry of disruptive innovation in self-rehabilitation into public healthcare systems.
To attain this ROSIA plans to develop an ICT Innovation Ecosystem for telerehabilitation that is able to integrate technology from third parties in a catalogue devised for clinical prescription.
Main dates
ROSIA PCP started January 2021 and will last 54 months. The call for tender was published in March 2022. The Phase 1 run for 3 months starting in October 2022. Phase 2 started in April 2023 for 10 months and Phase 3 is foreseen to last 14 months starting in April 2024.
PROGRESS STATUS
%
PHASE 0
Preparation STAGE PCP
Where participants’ functions are co-designed with all involved stakeholders, the open market consultation is co-created with the industry, and the tender documents are redacted and validated.
%
PHASE I
Where we develop a feasibility study of solutions from awarded bidders.
%
PHASE II
Where we develop prototypes of the most promising solutions from Phase 1
%
PHASE III
Where the best prototypes are tested in real life scenarios at each procurer’s site
ROSIA CALENDAR
Calendar Project
Start of the Project
01 Jan 21
–
OMC started
12 Jul 21
–
OMC concluded
3 Sept 21
Call for tender process
30 Jun 22
–
Phase 1 started
28 Oct 22
–
Phase 1 concluded
17 Feb 22
Phase 2 started
25 Apr 23
–
Phase 2 concluded
8 Feb 24
Phase 3 started
5 Apr 24
–
Phase 3 concluded
30 May 25
End of Project
30 Jun 25
–
How will ROSIA make a difference?
ROSIA will design, validate and assess a state-of-the-art model to address a common need: self-management of telerehabilitation, supported by community integrated care.
To do so:
– We will unlock the market to existing disruptive SMEs.
– We will pull existing research solutions out from the lab.
– We will get ready for scale-up.
And furthermore:
– We will generate evidence on results and guidelines, to improve and motivate participation in a PCP.
